Not applicableStudy completedNCT00676624What this trial is testingInfectious Causes of UveitisWho this might be right forUveitis Statens Serum Institut 100
Testing effectiveness (Phase 2)Ended earlyNCT04762160What this trial is testingSYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular LymphomaWho this might be right forFollicular Lymphoma Epizyme, Inc. 5
Not applicableActive Not RecruitingNCT06899308What this trial is testingHealth Surveillance at Constructor University Bremen (CUB)Who this might be right forSocial Isolation or LonelinessAnxietyAnxiety Depression (Mild or Not Persistent)+12 more Jacobs University Bremen gGmbH 373
Not applicableStudy completedNCT02626624What this trial is testingSafety and Efficacy of the CarboClear Pedicle Screw SystemWho this might be right forDegenerative Disc DiseaseSpondylolisthesis, Grade 1 CarboFix Orthopedics Ltd. 57
Large-scale testing (Phase 3)Study completedNCT00278408What this trial is testingRituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma German High-Grade Non-Hodgkin's Lymphoma Study Group 700
Early research (Phase 1)Study completedNCT00390117What this trial is testingAT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 34
Early research (Phase 1)Study completedNCT03381768What this trial is testingPeptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular LymphomaWho this might be right forFollicular Lymphoma Lars Møller Pedersen 8
Testing effectiveness (Phase 2)Ended earlyNCT00265928What this trial is testingBortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Virginia 46
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)UnknownNCT00002481What this trial is testingCombination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma St. Luke's Medical Center
Not applicableStudy completedNCT01169311What this trial is testingSafety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy ProcedureWho this might be right forHemorrhoid Medtronic - MITG 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598998What this trial is testingPembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell LymphomasWho this might be right forAnaplastic Large Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeRecurrent Anaplastic Large Cell Lymphoma+17 more City of Hope Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00987493What this trial is testingRituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell LymphomaWho this might be right forLymphoma Swiss Cancer Institute 49
Testing effectiveness (Phase 2)Study completedNCT02401048What this trial is testingA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory LymphomasWho this might be right forDiffuse Large B-Cell LymphomaFollicular Lymphoma Pharmacyclics LLC. 61
Not applicableLooking for participantsNCT05846763What this trial is testingObinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World StudyWho this might be right forFollicular Lymphoma Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableStudy completedNCT00900484What this trial is testingSWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 458
Testing effectiveness (Phase 2)Study completedNCT00004198What this trial is testingVaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT01258998What this trial is testingStudy of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02446457What this trial is testingRituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+1 more M.D. Anderson Cancer Center 53